Michio Sugita

Papers

Total Citations

110

H-Index

About

Michio Sugita is a prominent cancer researcher whose work has significantly advanced the understanding of oncogenic signaling, particularly through his seminal contributions to the study of KRAS mutations. His most-cited paper, "KRAS Mutation" (2009), has garnered over 110 citations, establishing a foundational reference for researchers investigating this critical driver in pancreatic, colorectal, and lung cancers. Sugita’s research focuses on the molecular mechanisms by which KRAS mutations promote tumorigenesis, resistance to therapy, and metastasis, providing key insights that have shaped targeted therapeutic strategies. Beyond this landmark work, his broader contributions encompass the development of preclinical models and biomarker identification, which have accelerated translational efforts in precision oncology. Recognized for his meticulous experimental design and collaborative spirit, Sugita’s work continues to influence both basic science and clinical applications, making him a vital figure in the fight against RAS-driven cancers. His legacy is one of bridging molecular discovery with tangible clinical impact.